Valuation: Bio-Rad Laboratories, Inc.

Market Cap 9.78B 8.74B 8.13B 7.39B 13.96B 947B 14.02B 97.84B 38.34B 483B 36.74B 35.94B 1,549B P/E 2026 *
44x
P/E 2027 * 43x
Enterprise Value 9.04B 8.07B 7.51B 6.83B 12.89B 875B 12.95B 90.35B 35.4B 446B 33.93B 33.19B 1,431B EV / Sales 2026 *
3.52x
EV / Sales 2027 * 3.36x
Free-Float
60.17%
Yield 2026 *
-
Yield 2027 * -
1 day-1.19%
1 week-4.95%
Current month-4.42%
1 month-2.04%
3 months+21.32%
6 months+25.28%
Current year+19.16%
1 week 353.97
Extreme 353.97
390
1 month 353.3
Extreme 353.3
390
Current year 236.73
Extreme 236.73
396.23
1 year 236.73
Extreme 236.73
396.23
3 years 211.43
Extreme 211.43
396.23
5 years 211.43
Extreme 211.43
798.97
10 years 154.89
Extreme 154.89
832.7
Manager TitleAgeSince
Chief Executive Officer 76 2002-12-31
President 61 2024-09-08
Director of Finance/CFO 55 2024-04-14
Director TitleAgeSince
Chairman 76 2011-12-31
Director/Board Member 73 2017-04-24
Director/Board Member 79 2017-04-24
Date Insider Type Main position Quantity % Market Cap. Importance
9/6/26 Exercice

General Counsel

1,841 0.0085%
9/6/26 Exercice

Chief Executive Officer

8,764 0.0404%
9/6/26 Exercice

Chief Financial Officer

3,854 0.0178%
Change 5-day change 1-year change 3-year change Capi.($)
-1.19%-4.95%+18.87%+4.14% 9.78B
+1.42%+0.92%-23.11%+12.01% 172B
+3.41%+4.18%-4.12%+28.55% 113B
+1.15%-1.85%-23.28%+10.28% 106B
+0.27%+1.56%-46.56%-11.83% 75.31B
+0.19%+3.01%+2.34%+72.95% 61.8B
+0.12%+3.62%+15.06%+62.75% 52.93B
+1.87%+3.54%+0.22%-27.23% 50.05B
+1.19%-0.72%-17.38%+22.17% 40.81B
-0.23%+1.19% - - 31.81B
Average +0.82%+2.10%-8.66%+19.31% 71.44B
Weighted average by Cap. +1.27%+2.29%-14.66%+18.92%

Financials

2026 *2027 *
Net sales 2.57B 2.29B 2.13B 1.94B 3.67B 249B 3.68B 25.69B 10.07B 127B 9.65B 9.44B 407B 2.62B 2.34B 2.18B 1.98B 3.74B 254B 3.76B 26.24B 10.28B 129B 9.85B 9.64B 416B
Net income 225M 201M 187M 170M 321M 21.76B 322M 2.25B 881M 11.09B 844M 826M 35.6B 230M 205M 191M 174M 328M 22.23B 329M 2.3B 900M 11.33B 863M 844M 36.37B
Net Debt -749M -669M -622M -566M -1.07B -72.49B -1.07B -7.49B -2.93B -36.96B -2.81B -2.75B -119B -965M -862M -802M -730M -1.38B -93.43B -1.38B -9.65B -3.78B -47.64B -3.63B -3.55B -153B
Projected Income Statement - Annual - Bio-Rad Laboratories, Inc.
Logo Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
Employees
7,450
Date Price Change Volume
26-10-12 US$361.03 -1.40% 37,921
26-10-09 US$366.16 +1.60% 138,984
26-10-08 US$360.40 -2.04% 312,024
26-10-07 US$367.92 -0.25% 251,904
26-10-06 US$368.83 -2.89% 162,538
Trader
Investor
Global
Quality
ESG MSCI
BBB
Ratings Surperformance© - Bio-Rad Laboratories, Inc.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
366.16USD
Average target price
328.33USD
Spread / Average Target
-10.33%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Bio-Rad Laboratories, Inc.